Back
Gossamer Bio 10K Form
Buy
63
GOSS
Gossamer Bio
Last Price:
$1.45
Seasonality Move:
-16.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GOSS News And Ratings
See the #1 stock for the next 7 days that we like better than GOSS
GOSS Financial Statistics
Sales & Book Value
Annual Sales: | $114.7M |
---|---|
Cash Flow: | $-35.5M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.13 |
Price / Book: | 11.14 |
Profitability
EPS (TTM): | -0.26000 |
---|---|
Net Income (TTM): | $-56.5M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Gossamer Bio Earnings Forecast
Key Gossamer Bio Financial Ratios
-
The Research & Development expenses have been 120.74% of Revenue.
-
The Net Earning history of GOSS is -49.28% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 4 years.
Gossamer Bio Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | GOSS |
CUSIP: | 38341P |
Website: | gossamerbio.com |
Debt
Debt-to-Equity Ratio: | 6.7 |
---|---|
Current Ratio: | 6.88 |
Quick Ratio: | 6.66 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
GOSS Technical Analysis vs Fundamental Analysis
Buy
63
Gossamer Bio (GOSS)
is a Buy
Is Gossamer Bio a Buy or a Sell?
-
Gossamer Bio stock is rated a BuyThe current Gossamer Bio [GOSS] share price is $1.45. The Score for GOSS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.